# Venus Medtech to acquire Keystone Heart

Venus Medtech signed an agreement to acquire Keystone Heart Ltd., a medical device company making the TriGUARD 3 cerebral embolic protection device. The acquisition gives Venus Medtech international rights to the device and establishes a presence in the US and EMEA.

- Type: Acquisition
- Announced: 2018-09-25
- Status: announced
- Products: TriGUARD 3 cerebral embolic protection device, transcatheter heart valve systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Venus Medtech](https://endata.com/companies/34506.md) (acquirer)
- [Keystone Heart](https://endata.com/companies/34507.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/venus-medtech-announces-agreement-to-acquire-keystone-heart-ltd-300718151.html), 2018-09-25: "It is of utmost importance to us that our devices improve the quality life of the patients whom receive them."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.